Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents

Wenli Zhang, Jiri Vajsar, Pinjiang Cao, Galen Breningstall, Charlotta Diesen, William Dobyns, Ralph Herrmann, Anna Elina Lehesjoki, Alice Steinbrecher, Beril Talim, Tatsushi Toda, Haluk Topaloglu, Thomas Voit, Harry Schachter

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

Objectives: Mutations disrupting the interaction of extra-cellular ligands and α-dystroglycan are responsible for an etiologically heterogeneous group of autosomal recessive congenital muscular dystrophies (CMD) that can have associated brain and eye abnormalities. The objective is to develop a diagnostic test for one of these CMDs, Muscle-Eye-Brain disease (MEB), due to mutations in the gene encoding Protein O-Mannosyl β-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1). Design and Methods: POMGnT1 enzyme activity was determined in extracts of muscle biopsies from four MEB patients and various controls using commercially available reagents. Results: All four MEB muscle samples showed a highly significant decrease in POMGnT1 activity relative to controls. Conclusions: The assay of POMGnT1 activity in MEB muscle provides a rapid and relatively simple diagnostic test for this disease. CMDs associated with brain malformations such as MEB, WWS and FCMD are heterogenous in clinical presentation and on radiologic examination, suggesting that POMGnT1 assays of muscle biopsies should be used as a screening procedure for MEB in all CMD patients associated with brain malformations.

Original languageEnglish (US)
Pages (from-to)339-344
Number of pages6
JournalClinical Biochemistry
Volume36
Issue number5
DOIs
StatePublished - Jul 2003
Externally publishedYes

Keywords

  • Brain
  • Diagnosis
  • Dystrophy
  • Enzyme Assay
  • Eye
  • Glycosyltransferase
  • Muscle
  • N-acetylglucosaminyltransferase
  • Neuromuscular

Fingerprint Dive into the research topics of 'Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents'. Together they form a unique fingerprint.

Cite this